Author:
Al Jammaz I.,Al-Otaibi B.,Al-Malki Y.,Abousekhrah A.,Okarvi S. M.
Abstract
Abstract
Background
There is a need to develop new and more potent radiofluorinated peptide and their hybrid conjugates for multiple-receptors targeting properties that overexpress on many cancers.
Methods
We have synthesized MUC1-[18F] SFB and MUC1-FA-[18F] SFB hybrid conjugates using a convenient and one-step nucleophilic displacement reaction. In vitro cell binding and in vivo evaluation in animals were performed to determine the potential of these radiolabeled compounds.
Results
Radiochemical yields for MUC1-[18F] SFB and MUC1-FA-[18F] SFB conjugates were greater than 70% in less than 30 min synthesis time. Radiochemical purities were greater than 97% without HPLC purification, which makes these approaches amenable to automation. In vitro studies on MCF7 breast cancer cells showed that the significant amounts of the radiofluorinated conjugates were associated with cell fractions and held good affinity and specificity for MCF7 cells. In vivo characterization in Balb/c mice revealed rapid blood clearance with excretion predominantly by urinary as well as hepatobiliary systems for MUC1-[18F] SFB and MUC1-FA-[18F] SFB, respectively.
Biodistribution in SCID mice bearing MCF7 xenografts, demonstrated excellent tumor uptake (12% ID/g) and favorable kinetics for MUC1-FA-[18F] SFB over MUC1-[18F]SFB. The tumor uptake was blocked by the excess co-injection of cold peptides suggesting the receptor-mediated process.
Conclusion
Initial PET/CT imaging of SCID mice with MCF7 xenografts, confirmed these observations. These results demonstrate that MUC1-FA-[18F] SFB may be a useful PET imaging probe for breast cancer detection and monitoring tumor response to the treatment.
Funder
King Abdulaziz City for Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Radiology, Nuclear Medicine and imaging,Analytical Chemistry
Reference35 articles.
1. Agrawal B, Reddish MA, Christian B, VanHeele A, Tang L, Koganty RR, et al. The antiMUC1 monoclonal antibody BCP8 can be used to isolate and identify putative major histocompatibility complex class 1 associated amino acid sequences. Cancer Res. 1998;58:5151–6.
2. AlJammaz I, Al-Otaibi B, Abousekhrah A, Okarvi S. Rapid and one-step radiofluorination of bioactive peptides: potential PET radiopharmaceuticals. J Appl Radiat Isot. 2014;91:17–23.
3. AlJammaz I, Al-Otaibi B, Okarvi S, Amartey J. Novel synthesis of [18F]-fluorobenzene and pyridinecarbohydrazide-folates as potential PET radiopharmaceuticals. J Label Compd Radiopharm. 2006;49:125–37.
4. Antony AC. The biological chemistry of folate receptors. Blood. 1992;79:2807–20.
5. Boerman O, Oyen W, Corstens F. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals. Semin Nucl Med. 2000;30:195–08.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献